Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Scientometrics

World J Gastrointest Oncol. Nov 15, 2024; 16(11): 4489-4505
Published online Nov 15, 2024. doi: 10.4251/wjgo.v16.i11.4489

Table 3 The 15 most productive institutions regarding olaparib and pancreatic cancer research

Rank	Institution	Country	Counts	TLCS	TGCS
1	Memorial Sloan-Kettering Cancer Center	United States	14	147	1667
2	AstraZeneca	United Kingdom	13	208	2755
3	University of Michigan	United States	10	36	752
4	Harvard Medical School	United States	7	15	173
5	University of Bologna	Italy	7	6	92
6	University of Pennsylvania	United States	7	62	1254
7	Dana-Farber Cancer Institute	United States	6	21	633
8	Beaujon Hospital	France	6	121	931
9	Tel Aviv University	Israel	6	110	907
10	University of Oxford	United Kingdom	6	18	192
11	University of Texas, MD Anderson Cancer Center	United States	6	27	859
12	Vall d’Hebron University Hospital	Spain	6	130	1163
13	Sheba Medical Center	Israel	5	70	1220
14	University College London	United Kingdom	5	127	1150
15	University of Glasgow	United Kingdom	5	7	105

TLCS: Total local citation score; TGCS: Total global citation score.

Citation: Feng X, Chai YH, Jiang KX, Jiang WB, Chen WC, Pan Y. Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective. World J Gastrointest Oncol 2024; 16(11): 4489-4505
URL: https://www.wjgnet.com/1948-5204/full/v16/i11/4489.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i11.4489

Feng X, Chai YH, Jiang KX, Jiang WB, Chen WC, Pan Y. Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective. World J Gastrointest Oncol 2024; 16(11): 4489-4505 [PMID: 39554747 DOI: 10.4251/wjgo.v16.i11.4489]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.